Glycine-Proline-Glutamate (GPE) — Indexed Studies

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

Bonchev A

Melanotan II: a possible cause of renal infarction: review of the literature and case report.

Peters B, Hadimeri H, Wahlberg R et al.

Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?

Yassin Alsabbagh A, Bhujel N, Singh RP

Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

Inozemtseva LS, Yatsenko KA, Glazova NY et al.

Barbie drug identification: Not a child's play.

Deville M, Charlier C

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

Weirath NA, Haskell-Luevano C

Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

Liu H, Liu Z, Wong HK et al.

Multiple metabolic signals in the CeA regulate feeding: The role of AMPK.

Castro G, Mendes NF, Weissmann L et al.

5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.

Todorovic M, Blanc A, Wang Z et al.

Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner.

Ford CL, McDonough AA, Horie K et al.

Melanotan-II reverses memory impairment induced by a short-term HF diet.

Wekwejt P, Wojda U, Kiryk A

Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.

Wagner S, Brierley DI, Leeson-Payne A et al.

Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.

Eliason NL, Martin L, Low MJ et al.

Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons.

Islam MT, Rumpf F, Tsuno Y et al.

[The risks of tanning with the Barbie drug].

Eijmael MJPM, Janmaat CJ, Briët-Schipper EMN

CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.

Tomassi S, Dimmito MP, Cai M et al.

Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity.

Hong TI, Hwang KS, Choi TI et al.

Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.

Gilhooley E, Daly S, McKenna D

Depletion of Alpha-Melanocyte-Stimulating Hormone Induces Insatiable Appetite and Gains in Energy Reserves and Body Weight in Zebrafish.

Hsieh YW, Tsai YW, Lai HH et al.

Intracerebroventricular administration of α-melanocyte-stimulating hormone (α-MSH) enhances thigmotaxis and induces anxiety-like behavior in the goldfish Carassius auratus.

Watanabe K, Konno N, Nakamachi T et al.

The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections.

Fortin SM, Chen J, Grill HJ et al.

Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.

Lau JKY, Tian M, Shen Y et al.

Restoration of Cardiac Function After Myocardial Infarction by Long-Term Activation of the CNS Leptin-Melanocortin System.

Gava FN, da Silva AA, Dai X et al.

Melanotan Tanning Injection: A Rare Cause of Priapism.

Mallory CW, Lopategui DM, Cordon BH

Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.

René P, Lanfray D, Richard D et al.

Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice.

McMillan TR, Forster MAM, Short LI et al.

LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs.

Mestria S, Odoardi S, Frison G et al.

G(q)α/G(11)α deficiency in dorsomedial hypothalamus leads to obesity resulting from decreased energy expenditure and impaired sympathetic nerve activity.

Wilson EA, Sun H, Cui Z et al.

Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor.

Zhou Y, Mowlazadeh Haghighi S, Liu Z et al.

A sentinel population: The public health benefits of monitoring enhanced body builders.

McVeigh J, Salinas M, Ralphs R

CAPS2 deficiency induces proopiomelanocortin accumulation in pituitary and affects food intake behavior in mice.

Fujima S, Amemiya N, Arima T et al.

Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II.

Chen B, Vavrek M, Gundersdorf R et al.

Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.

Yu H, Chhabra KH, Thompson Z et al.

Melanocortin regulation of histaminergic neurons via perifornical lateral hypothalamic melanocortin 4 receptors.

Michael NJ, Caron A, Lee CE et al.

Application of Dimedone Enamines as Protecting Groups for Amines and Peptides.

Chithanna S, Vyasamudri S, Yang DY

Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition.

Wu JC, Tsai HE, Hsiao YH et al.

Sites and sources of sympathoexcitation in obese male rats: role of brain insulin.

Shi Z, Zhao D, Cassaglia PA et al.

Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism.

Minakova E, Lang J, Medel-Matus JS et al.

Glucose-regulated protein 78 binds to and regulates the melanocortin-4 receptor.

Yoon YR, Lee TG, Choi MH et al.

A glimpse into the underground market of melanotan.

Callaghan Iii DJ

Limiting feeding to the active phase reduces blood pressure without the necessity of caloric reduction or fat mass loss.

Cote I, Toklu HZ, Green SM et al.

Melanotan II causes hypothermia in mice by activation of mast cells and stimulation of histamine 1 receptors.

Jain S, Panyutin A, Liu N et al.

The stimulatory G protein G(s)α is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism.

Podyma B, Sun H, Wilson EA et al.

Inherently Lean Rats Have Enhanced Activity and Skeletal Muscle Response to Central Melanocortin Receptors.

Gavini CK, Britton SL, Koch LG et al.

Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice.

da Silva AA, Freeman JN, Hall JE et al.

Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.

Côté I, Green SM, Morgan D et al.

The unregulated use of melanotan-II is of public health interest to Australian dermatologists.

Adler NR, Dowling JP, Pan Y

AgRP-Expressing Adrenal Chromaffin Cells Are Involved in the Sympathetic Response to Fasting.

Gupta R, Ma Y, Wang M et al.

Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

Côté I, Sakarya Y, Kirichenko N et al.

Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats.

Paiva L, Sabatier N, Leng G et al.